Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 10/20 | 0.67 |
| ▸ | MAPT | P10636 | 5/20 | 0.56 |
| ▸ | MEN1 | O00255 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | BCL2 | P10415 | 2/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.56 |
| ▸ | MAOA | P21397 | 1/20 | 0.56 |
| ▸ | APEX1 | P27695 | 1/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | DAPK1 | P53355 | 1/20 | 0.56 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30497048 | 1.00 | ELANE (0.67) | ELANEMAPTMEN1KMT2AMCL1 | |
| SCHEMBL5919605 | 0.92 | ELANE (0.63) | ELANEMAPTMEN1KMT2AMCL1 | |
| SCHEMBL9629402 | 0.90 | ELANE (0.70) | ELANEMAPTMEN1KMT2AMCL1 | |
| SCHEMBL7600157 | 0.83 | ELANE (0.48) | ELANEMAPTMEN1KMT2AMCL1 | |
| SCHEMBL11412142 | 0.81 | GABRA1 (0.46) | ELANEMAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL9282673 | 0.81 | MAOA (0.56) | ELANEMAPTMEN1KMT2AMCL1 | |
| SCHEMBL16225888 | 0.81 | ELANE (1.00) | ELANEMAPTMEN1KMT2AGABRA1 | |
| SCHEMBL7623901 | 0.81 | ELANE (0.57) | ELANEMAPTMEN1KMT2AMCL1 | |
| SCHEMBL4349729 | 0.81 | ELANE (0.47) | ELANEMAPTMEN1KMT2AMCL1 | |
| SCHEMBL7623905 | 0.81 | ELANE (0.57) | ELANEMAPTMEN1KMT2AMCL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023143608-A1 | COMPOSITION, METHOD FOR PREPARING SAME, AND USE THEREOF | 上海复东生物医药有限责任公司 | 2023-08-03 | — | — | WO | claimed |
| CN-116510024-A | Composition, preparation method and application thereof | 上海复东生物医药有限责任公司 | 2023-08-01 | — | — | CN | claimed |
| WO-2023068423-A1 | COMPLEX ANTICANCER DRUG COMPOSITION USING PHOTOREACTIVITY AND PREPARATION METHOD THEREFOR | 닥터아이앤비(주) | 2023-04-27 | — | — | WO | claimed |
| CN-110693863-A | Application of pharmaceutical composition in preparation of medicine for treating acute myeloid leukemia | 浙江大学 | 2020-01-17 | — | — | CN | claimed |
| US-9801898-B2 | Glutamate dehydrogenase 1 inhibitors and methods of treating cancer | EMORY UNIVERSITY | 2017-10-31 | — | — | US | claimed |
| US-20160228466-A1 | Glutamate Dehydrogenase 1 Inhibitors and Methods of Treating Cancer | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-08-11 | — | — | US | claimed |
| EP-4653523-A1 | CULTURE MEDIUM, PRODUCTION METHOD, AND CELL PREPARATION | National University Corporation Kumamoto University (JP) | 2025-11-26 | — | — | EP | disclosed |
| WO-2024154828-A1 | CULTURE MEDIUM, PRODUCTION METHOD, AND CELL PREPARATION | 国立大学法人熊本大学 | 2024-07-25 | — | — | WO | disclosed |
| WO-2023143608-A1 | COMPOSITION, METHOD FOR PREPARING SAME, AND USE THEREOF | 上海复东生物医药有限责任公司 | 2023-08-03 | — | — | WO | disclosed |
| CN-116510024-A | Composition, preparation method and application thereof | 上海复东生物医药有限责任公司 | 2023-08-01 | — | — | CN | disclosed |
| WO-2023068423-A1 | COMPLEX ANTICANCER DRUG COMPOSITION USING PHOTOREACTIVITY AND PREPARATION METHOD THEREFOR | 닥터아이앤비(주) | 2023-04-27 | — | — | WO | disclosed |
| US-20200188431-A1 | GLUTAMINE DEHYDROGENASE INHIBITORS FOR USE IN MUSCLE REGENERATION | KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D (BE) | 2020-06-18 | — | — | US | disclosed |
| CN-110693863-A | Application of pharmaceutical composition in preparation of medicine for treating acute myeloid leukemia | 浙江大学 | 2020-01-17 | — | — | CN | disclosed |
| US-20140042026-A1 | ELECTROCHEMICAL SENSORS | SENSOR INNOVATIONS, INC. (US) | 2014-02-13 | — | — | US | disclosed |
| US-20130248364-A1 | ELECTROCHEMICAL SENSORS | SENSOR INNOVATIONS | 2013-09-26 | — | — | US | disclosed |
| US-20120187000-A1 | ELECTROCHEMICAL SENSORS | Sensor Innovation, Inc. A Delaware Corporation (US) | 2012-07-26 | — | — | US | disclosed |
| WO-2012083258-A2 | ELECTROCHEMICAL SENSORS | SENSOR INNOVATIONS, INC. (US) | 2012-06-21 | — | — | WO | disclosed |
| CN-101765766-A | Semiconductor electrochemical sensor | SENSOR INNOVATIONS INC | 2010-06-30 | — | — | CN | disclosed |
| EP-2171440-A1 | SEMICONDUCTOR ELECTROCHEMICAL SENSORS | Sensor Innovations Inc. (US) | 2010-04-07 | — | — | EP | disclosed |
| WO-2008154409-A1 | SEMICONDUCTOR ELECTROCHEMICAL SENSORS | SENSOR INNOVATIONS INC. (US) | 2008-12-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200188431-A1 | GLUTAMINE DEHYDROGENASE INHIBITORS FOR USE IN MUSCLE REGENERATION | GLUL, GLS2, GLS | ELANE 2473/4885MAPT 4363/4885MEN1 4556/4885 |
| US-20160228466-A1 | Glutamate Dehydrogenase 1 Inhibitors and Methods of Treating Cancer | ALDH7A1, ALDH1A1, DPYD | ELANE 1635/4885MAPT 4069/4885MEN1 2249/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.